Vis enkel innførsel

dc.contributor.authorNémeth, János
dc.contributor.authorTapasztó, Beáta
dc.contributor.authorAclimandos, Wagih A.
dc.contributor.authorKestelyn, Philippe
dc.contributor.authorJonas, Jost B.
dc.contributor.authorDe Faber, Jan-Tjeerd H. N.
dc.contributor.authorJanuleviciene, Ingrida
dc.contributor.authorGrzybowski, Andrzej
dc.contributor.authorNagy, Zoltán Zsolt
dc.contributor.authorPärssinen, Olavi
dc.contributor.authorGuggenheim, Jeremy A.
dc.contributor.authorAllen, Peter M.
dc.contributor.authorBaraas, Rigmor C.
dc.contributor.authorSaunders, Kathryn J
dc.contributor.authorFlitcroft, Daniel Ian
dc.contributor.authorGray, Lyle S.
dc.contributor.authorPolling, Jan Roelof
dc.contributor.authorHaarman, Annechien E. G.
dc.contributor.authorTideman, J. Willem L.
dc.contributor.authorWolffsohn, James Stuart
dc.contributor.authorWahl, Siegfried
dc.contributor.authorMulder, Jeroen A.
dc.contributor.authorSmirnova, Irina Yurievna
dc.contributor.authorFormenti, Marino
dc.contributor.authorRadhakrishnan, Hema
dc.contributor.authorResnikoff, Serge
dc.date.accessioned2022-02-10T10:19:27Z
dc.date.available2022-02-10T10:19:27Z
dc.date.created2021-06-21T16:47:43Z
dc.date.issued2021
dc.identifier.citationNémeth, J., Tapasztó, B., Aclimandos, W. A., Kestelyn, P., Jonas, J. B., De Faber, J.-T. H. N., Januleviciene, I., Grzybowski, A., Nagy, Z. Z., Pärssinen, O., Guggenheim, J. A., Allen, P. M., Baraas, R. C., Saunders, K. J., Flitcroft, D. I., Gray, L. S., Polling, J. R., Haarman, A. E. G., Tideman, J. W. L., Wolffsohn, J. S., Wahl, S., Mulder, J. A., Smirnova, I. Y., Formenti, M., Radhakrishnan, H. & Resnikoff, S. (2021). Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute. European Journal of Ophthalmology, 31(3), 853-883.en_US
dc.identifier.issn1120-6721
dc.identifier.urihttps://hdl.handle.net/11250/2978209
dc.description.abstractThe prevalence of myopia is increasing extensively worldwide. The number of people with myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 billion by 2050, unless preventive actions and interventions are taken. The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the most common cause of irreversible vision impairment and blindness worldwide and also in Europe. These prevalence estimates indicate the importance of reducing the burden of myopia by means of myopia control interventions to prevent myopia onset and to slow down myopia progression. Due to the urgency of the situation, the European Society of Ophthalmology decided to publish this update of the current information and guidance on management of myopia. The pathogenesis and genetics of myopia are also summarized and epidemiology, risk factors, preventive and treatment options are discussed in details.en_US
dc.language.isoengen_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleUpdate and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Instituteen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© The Author(s) 2021.en_US
dc.source.pagenumber853-883en_US
dc.source.volume31en_US
dc.source.journalEuropean Journal of Ophthalmologyen_US
dc.source.issue3en_US
dc.identifier.doihttps://doi.org/10.1177/1120672121998960
dc.identifier.cristin1917458
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal